These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 10208287

  • 1. A double-blind crossover comparison of clomipramine and desipramine in the treatment of panic disorder.
    Sasson Y, Iancu I, Fux M, Taub M, Dannon PN, Zohar J.
    Eur Neuropsychopharmacol; 1999 Mar; 9(3):191-6. PubMed ID: 10208287
    [Abstract] [Full Text] [Related]

  • 2. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators.
    Lecrubier Y, Bakker A, Dunbar G, Judge R.
    Acta Psychiatr Scand; 1997 Feb; 95(2):145-52. PubMed ID: 9065680
    [Abstract] [Full Text] [Related]

  • 3. Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators.
    Lecrubier Y, Judge R.
    Acta Psychiatr Scand; 1997 Feb; 95(2):153-60. PubMed ID: 9065681
    [Abstract] [Full Text] [Related]

  • 4. Electrocardiographic changes during desipramine and clomipramine treatment in children and adolescents.
    Leonard HL, Meyer MC, Swedo SE, Richter D, Hamburger SD, Allen AJ, Rapoport JL, Tucker E.
    J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1460-8. PubMed ID: 8543513
    [Abstract] [Full Text] [Related]

  • 5. A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.
    Gordon CT, State RC, Nelson JE, Hamburger SD, Rapoport JL.
    Arch Gen Psychiatry; 1993 Jun; 50(6):441-7. PubMed ID: 8498878
    [Abstract] [Full Text] [Related]

  • 6. Serum levels of clomipramine and desmethylclomipramine and clinical improvement in panic disorder.
    Marcourakis T, Gorenstein C, Ramos RT, da Motta Singer J.
    J Psychopharmacol; 1999 Jun; 13(1):40-4. PubMed ID: 10221358
    [Abstract] [Full Text] [Related]

  • 7. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness.
    Hollander E, Allen A, Kwon J, Aronowitz B, Schmeidler J, Wong C, Simeon D.
    Arch Gen Psychiatry; 1999 Nov; 56(11):1033-9. PubMed ID: 10565503
    [Abstract] [Full Text] [Related]

  • 8. Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder.
    Bakker A, van Dyck R, Spinhoven P, van Balkom AJ.
    J Clin Psychiatry; 1999 Dec; 60(12):831-8. PubMed ID: 10665629
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder.
    Nair NP, Bakish D, Saxena B, Amin M, Schwartz G, West TE.
    Anxiety; 1996 Dec; 2(4):192-8. PubMed ID: 9160622
    [Abstract] [Full Text] [Related]

  • 13. Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study.
    Nelson JC, Mazure CM, Jatlow PI, Bowers MB, Price LH.
    Biol Psychiatry; 2004 Feb 01; 55(3):296-300. PubMed ID: 14744472
    [Abstract] [Full Text] [Related]

  • 14. The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial.
    Bandelow B, Broocks A, Pekrun G, George A, Meyer T, Pralle L, Bartmann U, Hillmer-Vogel U, Rüther E.
    Pharmacopsychiatry; 2000 Sep 01; 33(5):174-81. PubMed ID: 11071019
    [Abstract] [Full Text] [Related]

  • 15. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial.
    Freeman EW, Rickels K, Sondheimer SJ, Polansky M.
    Arch Gen Psychiatry; 1999 Oct 01; 56(10):932-9. PubMed ID: 10530636
    [Abstract] [Full Text] [Related]

  • 16. A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.
    Musselman DL, Somerset WI, Guo Y, Manatunga AK, Porter M, Penna S, Lewison B, Goodkin R, Lawson K, Lawson D, Evans DL, Nemeroff CB.
    J Clin Psychiatry; 2006 Feb 01; 67(2):288-96. PubMed ID: 16566626
    [Abstract] [Full Text] [Related]

  • 17. Preliminary report: placebo-controlled, double-blind study of the clinical and metabolic effects of desipramine in panic disorder.
    Lydiard RB, Morton WA, Emmanuel NP, Zealberg JJ, Laraia MT, Stuart GW, O'Neil PM, Ballenger JC.
    Psychopharmacol Bull; 1993 Feb 01; 29(2):183-8. PubMed ID: 8290663
    [Abstract] [Full Text] [Related]

  • 18. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A.
    Encephale; 2008 Sep 01; 34(4):400-8. PubMed ID: 18922243
    [Abstract] [Full Text] [Related]

  • 19. Fluvoxamine and clomipramine in depressed hospitalised patients: results from a randomised, double-blind study.
    Ottevanger EA.
    Encephale; 1995 Sep 01; 21(4):317-21. PubMed ID: 7588171
    [Abstract] [Full Text] [Related]

  • 20. Differential response of seven subjects with autistic disorder to clomipramine and desipramine.
    Gordon CT, Rapoport JL, Hamburger SD, State RC, Mannheim GB.
    Am J Psychiatry; 1992 Mar 01; 149(3):363-6. PubMed ID: 1536276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.